GLP-1 mimetic drugs and the risk of exocrine pancreatic disease: Cell and animal studies
Finally, countries experiencing a new rise of SARS-CoV-2 positive cases such as the four major EU nations and UK, should promote the development of more rational treatment guidelines for COVID-19, taking due account of the above facts and considerations to avoid that the same mistakeif concerns on PAC are ascertainedmay be repeated in the next few months
Not every patient is an appropriate candidate for GLP-1 therapy, regardless of demand
Presented for research literature review only Asensio-Snchez VM et al
It is responsible for the transformation of triglycerides into energy, especially during low-intensity exercise, and at the same time it reduces lactic acid in the muscles and provides stable energy levels
GLP-1 medications are often used when diet, exercise, and other medicines have not provided enough benefit